Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tool for Evaluating the Effectiveness of the DENVER Protocol for Attention to Faces (Face) and the Development of Social Communication (Com) in Young Children With Autism Spectrum Disorder (ASD)

NCT06253793 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT06253793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06253793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tool for Evaluating the Effectiveness of the DENVER Protocol for Attention to Faces (Face) and the Development of Social Communication (Com) in Young Children With Autism Spectrum Disorder (ASD)
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Not yet recruiting
Start date
May 13, 2024
Completion date
May 31, 2028
Enrollment
90 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder